Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. PRGS
8. VKTX
9. CMPX
10. GS

Go back to Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief
Quest Diagnostics (NYSE: DGX) Delayed: 234.76 -10.12 (4.13%)
Previous Close $244.88    52 Week High $86.85 
Open $228.59    52 Week Low $59.66 
Day High $237.29    P/E 44.21 
Day Low $227.24    EPS $5.31 
Volume 2,719,258